Article
Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.
Frontiers in immunology - 1 Jan 2022
Li Huihuang, Zu Xiongbing, Hu Jiao, Xiao Zicheng, Cai Zhiyong, Gao Ning, Chen Jinbo
Abstract excerpt
Background: Though immune checkpoint inhibitors (ICIs) exhibit durable efficacy in bladder carcinomas (BLCAs), there are still a large portion of patients insensitive to ICIs treatment. Methods: We systematically evaluated the cuproptosis patterns in BLCA patients based on 46 cuproptosis related genes and correlated these cuproptosis patterns with tumor microenvironment (TME) phenotypes and immunotherapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
